?

Total Voting Rights and Capital

Inconformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the Company) hereby notifies the market of the following:

The Company's issued share capital as at 31 December 2013 consisted of 5,342,206,696 Ordinary Shares of 25p each, of which 487,433,663 Ordinary Shares were held in Treasury.

Therefore, thetotal number of voting rights in the Company is 4,854,773,033. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Sonja Arseni?

Company Secretariat

2 January 2014


This information is provided by RNS
The company news service from the London Stock Exchange
ENDTVRUGURAGUPCGAP
distributed by